Despite these limitations, we believe that our data acknowledges the diagnostic utility of [TIMP-2]∙[IGFBP7], which could offer an adjunctive tool in order to avoid AKI progression and perform different actions plan to enable the intensivist prioritise their clinical decision-making in the context of AKI any stage risk assessment. The gene discussed is IGFBP7; the disease is acute kidney injury.